1. Home
  2. SGMT vs GWRS Comparison

SGMT vs GWRS Comparison

Compare SGMT & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • GWRS
  • Stock Information
  • Founded
  • SGMT 2006
  • GWRS 2003
  • Country
  • SGMT United States
  • GWRS United States
  • Employees
  • SGMT N/A
  • GWRS N/A
  • Industry
  • SGMT
  • GWRS Water Supply
  • Sector
  • SGMT
  • GWRS Utilities
  • Exchange
  • SGMT Nasdaq
  • GWRS Nasdaq
  • Market Cap
  • SGMT 230.3M
  • GWRS 265.4M
  • IPO Year
  • SGMT 2023
  • GWRS 2010
  • Fundamental
  • Price
  • SGMT $6.15
  • GWRS $9.91
  • Analyst Decision
  • SGMT Strong Buy
  • GWRS
  • Analyst Count
  • SGMT 7
  • GWRS 0
  • Target Price
  • SGMT $26.57
  • GWRS N/A
  • AVG Volume (30 Days)
  • SGMT 461.6K
  • GWRS 40.6K
  • Earning Date
  • SGMT 11-12-2025
  • GWRS 11-05-2025
  • Dividend Yield
  • SGMT N/A
  • GWRS 3.06%
  • EPS Growth
  • SGMT N/A
  • GWRS N/A
  • EPS
  • SGMT N/A
  • GWRS 0.22
  • Revenue
  • SGMT N/A
  • GWRS $54,270,000.00
  • Revenue This Year
  • SGMT N/A
  • GWRS $8.11
  • Revenue Next Year
  • SGMT N/A
  • GWRS $6.71
  • P/E Ratio
  • SGMT N/A
  • GWRS $45.51
  • Revenue Growth
  • SGMT N/A
  • GWRS 4.33
  • 52 Week Low
  • SGMT $1.73
  • GWRS $9.27
  • 52 Week High
  • SGMT $11.41
  • GWRS $13.98
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 30.58
  • GWRS 52.70
  • Support Level
  • SGMT $6.77
  • GWRS $9.68
  • Resistance Level
  • SGMT $7.35
  • GWRS $9.97
  • Average True Range (ATR)
  • SGMT 0.41
  • GWRS 0.23
  • MACD
  • SGMT -0.07
  • GWRS 0.04
  • Stochastic Oscillator
  • SGMT 5.57
  • GWRS 82.05

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About GWRS Global Water Resources Inc.

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.

Share on Social Networks: